CPE Consultants, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education
Requirements for CE Credit
Andrew Ahmann , MD
Brief Bio : Dr. Andrew Ahmann is Professor of Medicine and the Director of the Oregon Health and Science University (OHSU) Harold Schnitzer Diabetes Health Center at OHSU. He has been chair of the Oregon Diabetes Guidelines Committee and the Oregon Diabetes Collaborative Program. He volunteers in many capacities for diabetes causes regional and nationally. He served on the ADA Professional Practice Committee. He serves on committees for the Endocrine Society and AACE. He is President of The Portland Area Leadership board of the ADA. He is active in patient care, teaching, and clinical research.
Disclosure : I have the following financial relationships to disclose: Consultant/Speaker’s Bureau for: Boehringer Ingelheim; Calibra; Dynavax; Dexcom; Janssen; Merck; and Novo Nordisk Grant/Research Support from: Dexcom; Lexicon; Metronic; NovoNordisk; and Sanofi-Aventis and I will not discuss off label use and/or investigational use in my presentation.
Janet B. McGill, MD, MA, FACE
Brief Bio : Dr. Janet McGill is Professor of Medicine in the Division of Endocrinology, Metabolism and Lipid Research at Washington University School of Medicine in St. Louis, Missouri, and attending physician at Barnes-Jewish Hospital in St. Louis. She directed the fellowship in Endocrinology, Diabetes and Metabolism at Washington University from 2009 – 2016. Dr. McGill is nationally and internationally known for her work in clinical and translational research in Type 1 and Type 2 diabetes and diabetes complications. She has been the principal investigator and co-investigator or sub-investigator on over 200 clinical trials in diabetes, hypertension, hyperlipidemia, diabetic nephropathy, diabetic neuropathy and diabetes related devices. In addition to serving on steering and safety committees for international multi-centered clinical trials, she has been the lead investigator on sponsored studies and has served on DSMBs on short and long-term outcome studies. She is the PI of the GRADE and PERL studies at Washington University. Dr. McGill has published over 150 peer-reviewed articles, numerous commentaries and editorials, and 18 chapters, and she has edited two books. She has been on the editorial boards of several journals and has lectured nationally and internationally on diabetes and related topics. She is a member of the board of directors of AACE, and serves on several scientific and planning committees, and is active in the Endocrine Society and ADA. Dr. McGill graduated from the University of Michigan (bachelors), Northern Michigan University (master’s) and Michigan State College of Human Medicine. She was an intern, resident and chief resident at William Beaumont Hospital in Royal Oak, Michigan.
Disclosure : I have the following financial relationships to disclose: Consultant for: Dexcom; Horizon CME and Novo Nordisk Speaker’s Bureau for: Horizon CME Grant/Research Support from: BMS-AZ; Dexcom; Lexicon; and Novartis and I will not discuss off label use and/or investigational use in my presentation.